BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 21987539)

  • 1. Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.
    Goetghebeur MM; Wagner M; Khoury H; Levitt RJ; Erickson LJ; Rindress D
    Med Decis Making; 2012; 32(2):376-88. PubMed ID: 21987539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.
    Tony M; Wagner M; Khoury H; Rindress D; Papastavros T; Oh P; Goetghebeur MM
    BMC Health Serv Res; 2011 Nov; 11():329. PubMed ID: 22129247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of relevant information around non-core domains to support Multi-Criteria Decision Analysis (MCDA) for decision making.
    Bayón-Yusta JC; Gutiérrez-Iglesias A; Galnares-Cordero L; Gutiérrez-Ibarluzea I
    GMS Health Innov Technol; 2024; 18():Doc02. PubMed ID: 38655192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs.
    Kolasa K; Zwolinski KM; Kalo Z; Hermanowski T
    Orphanet J Rare Dis; 2016 Mar; 11():23. PubMed ID: 26965710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Health Technology Assessment during Nonalcoholic Steatohepatitis Drug Development: A Two-Round, Cross-Country, Multicriteria Decision Analysis.
    Angelis A; Thursz M; Ratziu V; O'Brien A; Serfaty L; Canbay A; Schiefke I; Costa JBE; Lecomte P; Kanavos P
    Med Decis Making; 2020 Aug; 40(6):830-845. PubMed ID: 32845234
    [No Abstract]   [Full Text] [Related]  

  • 6. A Step Toward the Development of the First National Multi-Criteria Decision Analysis Framework to Support Healthcare Decision Making in Saudi Arabia.
    Al-Jedai A; Almudaiheem H; Alruthia Y; Althemery A; Alabdulkarim H; Ojeil R; Alrumaih A; AlGhannam S; AlMutairi A; Hasnan Z
    Value Health Reg Issues; 2024 May; 41():100-107. PubMed ID: 38306770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting the Acceptance Criteria of Medicines in the Reimbursement List of Public Health Insurance of Iran, Using the "Borda" Method: a Pilot Study.
    Viyanchi A; Rasekh HR; Rajabzadeh Ghatari A; SafiKhani HR
    Iran J Pharm Res; 2015; 14(4):1305-16. PubMed ID: 26664402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment.
    Angelis A; Kanavos P
    Pharmacoeconomics; 2016 May; 34(5):435-46. PubMed ID: 26739955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making.
    Gauvreau CL; Schreyer L; Gibson PJ; Koo A; Ungar WJ; Regier D; Chan K; Hayeems R; Gibson J; Palmer A; Peacock S; Denburg AE
    Value Health; 2024 Mar; ():. PubMed ID: 38548179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a multiple criteria decision analysis framework for prioritizing high-impact health technologies in a regional health service.
    Sánchez-Martínez FI; Abellán-Perpiñán JM; Martínez-Pérez JE; Gómez-Torres JL
    Int J Technol Assess Health Care; 2024 Apr; 40(1):e21. PubMed ID: 38576122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.
    Takhar P; Geirnaert M; Gavura S; Beca J; Mercer RE; Denburg A; Muñoz C; Tadrous M; Parmar A; Dionne F; Boehm D; Chambers C; Craig E; Trudeau M; Cheung MC; Houlihan J; McDonald V; Pechlivanoglou P; Taylor M; Wasylenko E; Wranik WD; Chan KKW
    Curr Oncol; 2024 Apr; 31(4):1876-1898. PubMed ID: 38668044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of multi-criteria decision analysis in evaluating the value of drug-oriented intervention: a literature review.
    Su P; Zhi K; Xu H; Xiao J; Liu J; Wang Z; Liu Q; Yu Y; Dang H
    Front Pharmacol; 2024; 15():1245825. PubMed ID: 38720775
    [No Abstract]   [Full Text] [Related]  

  • 13. Assessing the Preferences for Criteria in Multi-Criteria Decision Analysis in Treatments for Rare Diseases.
    Schey C; Postma MJ; Krabbe PFM; Topachevskyi O; Volovyk A; Connolly M
    Front Public Health; 2020; 8():162. PubMed ID: 32457865
    [No Abstract]   [Full Text] [Related]  

  • 14. HTA - Algorithm or Process? Comment on "Expanded HTA: Enhancing Fairness and Legitimacy".
    Culyer AJ
    Int J Health Policy Manag; 2016 Aug; 5(8):501-505. PubMed ID: 27694664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenge of obtaining information necessary for multi-criteria decision analysis implementation: the case of physiotherapy services in Canada.
    Dionne F; Mitton C; Macdonald T; Miller C; Brennan M
    Cost Eff Resour Alloc; 2013 May; 11(1):11. PubMed ID: 23688138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An integration of hybrid MCDA framework to the statistical analysis of computer-based health monitoring applications.
    Hongxia W; Juanjuan G; Han W; Wenlong L; Yasir M; Xiaojing L
    Front Public Health; 2023; 11():1341871. PubMed ID: 38259786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of the TRansparent Uncertainty ASsessmenT (TRUST) Tool for Assessing Uncertainties in Health Economic Decision Models.
    Grimm SE; Pouwels X; Ramaekers BLT; Wijnen B; Knies S; Grutters J; Joore MA
    Pharmacoeconomics; 2020 Feb; 38(2):205-216. PubMed ID: 31709496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs.
    Alnaqbi KA; Elezbawy B; Fasseeh AN; Bangash AR; Elshamy A; Shendi H; Aftab MI; AlMarshoodi M; Gebran N; AlDhaheri N; Fahmy SA; Al Dallal S; Al Naeem W; Abaza S; Kaló Z
    Cureus; 2024 Feb; 16(2):e55215. PubMed ID: 38558740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.
    Abad MR; Alerany C; Alsina L; Granados EL; Neth O; Poveda JL; Rivière JG; Rodríguez-Gallego C; Tutein Nolthenius JB; Figueiredo R; Labazuy SS; Gil A
    Glob Reg Health Technol Assess; 2024; 11():124-130. PubMed ID: 38784663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloud service selection using multicriteria decision analysis.
    Whaiduzzaman M; Gani A; Anuar NB; Shiraz M; Haque MN; Haque IT
    ScientificWorldJournal; 2014; 2014():459375. PubMed ID: 24696645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.